-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2016 to Q2 2025.
- Outlook Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 37M shares, a 45.1% increase year-over-year.
- Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 18.5M shares, a 48.3% increase from 2023.
- Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 12.5M shares, a 94.1% decline from 2022.
- Outlook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 212M shares, a 38.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)